Physician profile
Joseph D Warner
NPI 1568573897
$2,094.98
in general payments reported to CMS, 2019-2025
14 companies · $516 in 2025
The $516 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $47.47 · 2021: $406 · 2022: $221 · 2023: $318 · 2024: $480 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $447.28 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $349.18 | 2022-2025 | Infuse, Miebo, Xiidra |
| Eyevance Pharmaceuticals LLC | $302.67 | 2019-2021 | |
| Oyster Point Pharma, INC. | $192.12 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Alcon Vision LLC | $173.69 | 2019-2025 | Total30, Precision 1 |
| Novartis Pharmaceuticals Corporation | $152.65 | 2019-2023 | |
| Coopervision INC. | $119.27 | 2024-2025 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $96.28 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $80.44 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $57.50 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.78 | 2021 | |
| Sight Sciences, INC. | $28.17 | 2020-2024 | Tearcare System |
| Spark Therapeutics, INC. | $27.23 | 2022 | |
| Harrow Eye, LLC | $24.72 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.